Israel preparing to attack Iran: Report

August 17, 2012

israelarmy

London, August 17: Israel is preparing for a ground attack on Iran before Christmas, after conducting commando dry runs in the Iraq desert, a media report said.

Top military officials in Tel Aviv believe they have until the end of the year to strike at Iran's nuclear programme, The Sun reported.

The main target would be a heavily fortified uranium enrichment plant at Fordo, near the holy city of Qom.

Israeli leaders have reportedly made it clear they are ready to launch military action alone - if the US does not help.

Late October or early November have been identified by intelligence analysts as a likely time because of the US elections Nov 6.

"We know the Israelis have been active in the Iraq desert, it would appear preparing forward bases for a ground assault. Bombing Iranian nuclear installations will most likely be a part of their plan, but the only way to confirm they have destroyed what they need to is to put boots on the ground," an unnamed British official was quoted as saying.

"It is a very big concern. Iran would have to retaliate, putting the region into an extremely dangerous situation," he said.

An "anonymous senior Israeli politician" -- believed to be Defence Minister Ehud Barak -- made it clear to The Sun that Israel had already decided to act alone.

"We can't wait to find out one morning that we relied on the Americans but were fooled because the Americans didn't act. Israel is strong and Israel is responsible, and will do what it has to do," the minister said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 8,2024

covid.jpg

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.